Irwin Naturals Inc.
IWINF · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.01 | -0.01 | -0.00 |
| FCF Yield | 36.36% | 45.99% | 12.12% | -131.50% |
| EV / EBITDA | -22.70 | -6.24 | -6.40 | -15.54 |
| Quality | ||||
| ROIC | -2.67% | -2.04% | -1.81% | -2.74% |
| Gross Margin | 40.90% | 44.67% | 49.35% | 41.38% |
| Cash Conversion Ratio | -0.56 | -0.30 | -0.12 | 2.75 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.27% | -3.53% | -1.65% | 0.03% |
| Free Cash Flow Growth | -37.21% | 85.76% | 108.73% | -56.40% |
| Safety | ||||
| Net Debt / EBITDA | -21.03 | -5.69 | -5.38 | -11.35 |
| Interest Coverage | -3.34 | -2.35 | -2.87 | -8.02 |
| Efficiency | ||||
| Inventory Turnover | 0.65 | 0.59 | 0.53 | 0.60 |
| Cash Conversion Cycle | 129.52 | 138.07 | 183.66 | 179.67 |